Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related conditions
characterized by systemic inflammation, a predominant IL-6 signature, an excellent response …

Objective. We propose a GCA probability score intended to help to riskstratify patients
referred by general practitioners with suspected GCA into those with high probability of GCA …

DEAR EDITOR, the novel coronavirus SARS-CoV-2, known as COVID-19, is continually
being observed to cause new and varied multisystem sequalae. There have been several …

Objectives This systematic review and meta-analysis aimed to evaluate the diagnostic value
of the halo sign in the assessment of GCA. Methods A systematic literature review was …

Colour Doppler ultrasonography is the first measure to allow objective bedside assessment
of GCA. This article discusses the evidence using the OMERACT filter. Consensus …

Objective GCA is the commonest primary systemic vasculitis in adults, with significant health
economic costs and societal burden. There is wide variation in access to secondary care …

This is an exciting time for the management of GCA. The National Institute for Health and Care
Excellence (NICE) and NHS England have approved tocilizumab (TCZ), an IL-6 receptor …

Background Giant cell arteritis (GCA) is a common large vessel vasculitis of the elderly, often
associated with sight loss. Glucocorticoids (GC remain the mainstay of treatment, although …

Ultrasound (US) scanning in the diagnosis of large vessel giant cell arteritis (LV-GCA) is
becoming more prevalent, with the advantage of being non-invasive and free of ionising …

Study Design Only patients treated with leflunomide were included. First, demographic
characteristics, disease duration before leflunomide start, previous and concomitant therapies, …